Belle Mead, NJ, United States of America

Hong Shen

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Belle Mead, NJ (US) (2021)
  • Princeton, NJ (US) (2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Therapeutics: The Contributions of Inventor Hong Shen

Introduction

Inventor Hong Shen, based in Belle Mead, NJ, has made significant strides in the field of biomedicine with his innovative work and patented inventions. With a total of two patents to his name, Shen's contributions focus on the development of antibodies that target specific receptors, paving the way for novel treatments in inflammatory diseases.

Latest Patents

Hong Shen's latest patents revolve around antibodies against the IL-7 receptor alpha subunit (IL-7Rα). These antibodies have been designed to bind specifically to IL-7Rα, demonstrating potential therapeutic applications in treating a variety of inflammatory diseases. Additionally, the patents cover the production of cells that generate these antibodies, along with polynucleotides encoding the necessary heavy and light chain regions, and the vectors that carry these polynucleotides. This innovative approach opens new avenues for therapeutic options in immunology.

Career Highlights

Shen is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company that focuses on discovering and developing innovative medicines. His work at the company reflects his commitment to advancing medical science and improving patient outcomes. The research he conducts contributes to BMS’s mission of addressing critical health needs through scientific innovation.

Collaborations

Throughout his career, Hong Shen has collaborated with notable peers, including Aaron Paul Yamniuk and Scott Ronald Brodeur. These collaborations not only highlight the importance of teamwork in scientific discovery but also underscore the diverse expertise that enhances the research outcomes and the development of effective therapeutics.

Conclusion

Hong Shen's contributions to the field of immunotherapy through his patents on IL-7 receptor antibodies exemplify the innovative spirit that drives scientific progress. His work is a testament to the impact that dedicated inventors can have in the realm of medicine, paving the way for future breakthroughs that may eventually lead to improved treatments for patients suffering from inflammatory diseases. Through his collaborations and efforts at Bristol-Myers Squibb, Shen continues to influence the landscape of therapeutic innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…